Trump’s Semaglutide Most Favored Nation Price Will ‘Supersede’ Medicare MFP

 
• By Cathy Kelly
  
The Trump Administration appears to be prioritizing its MFN price negotiations over the Medicare price negotiation program. (Screenshot of White House Broadcast)

More from Medicare

More from Government Payers